These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 19247190

  • 21. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
    Aurigemma C, Fattorossi A, Sestito A, Sgueglia GA, Farnetti S, Buzzonetti A, Infusino F, Landolfi R, Scambia G, Crea F, Lanza GA.
    Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M, Antman EM, Braunwald E, Murphy SA, Steg PG, Finkelstein A, Penny WF, Fridrich V, McCabe CH, Sabatine MS, Wiviott SD.
    J Am Coll Cardiol; 2009 Aug 18; 54(8):678-85. PubMed ID: 19679245
    [Abstract] [Full Text] [Related]

  • 24. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL, Kogushi M, Dastros-Pitei D, Flather M, Bhatt DL.
    Thromb Haemost; 2009 Jul 18; 102(1):111-9. PubMed ID: 19572075
    [Abstract] [Full Text] [Related]

  • 25. Role of platelet glycoprotein IIb/IIIa in ADP-activated platelet adhesion to aortic endothelial cells in vitro: observation with video-enhanced contrast microscopy.
    Tomita Y, Tanahashi N, Tomita M, Itoh Y, Yokoyama M, Takeda H, Schiszler I, Fukuuchi Y.
    Clin Hemorheol Microcirc; 2001 Jul 18; 24(1):1-9. PubMed ID: 11345228
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Study on conformational changes of GP IIb/IIIa complex during platelet activation].
    Peng L, Li J, Wu H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep 18; 20(9):459-61. PubMed ID: 11721407
    [Abstract] [Full Text] [Related]

  • 28. Distinct but critical roles for integrin alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin.
    Thornber K, McCarty OJ, Watson SP, Pears CJ.
    FEBS J; 2006 Nov 18; 273(22):5032-43. PubMed ID: 17032352
    [Abstract] [Full Text] [Related]

  • 29. Anti-platelet effects of bioactive compounds isolated from the bark of Rhus verniciflua Stokes.
    Jeon WK, Lee JH, Kim HK, Lee AY, Lee SO, Kim YS, Ryu SY, Kim SY, Lee YJ, Ko BS.
    J Ethnopharmacol; 2006 Jun 15; 106(1):62-9. PubMed ID: 16431050
    [Abstract] [Full Text] [Related]

  • 30. Thrombostatin inhibits induced canine coronary thrombosis.
    Hasan AA, Rebello SS, Smith E, Srikanth S, Werns S, Driscoll E, Faul J, Brenner D, Normolle D, Lucchesi BR, Schmaier AH.
    Thromb Haemost; 1999 Sep 15; 82(3):1182-7. PubMed ID: 10494785
    [Abstract] [Full Text] [Related]

  • 31. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
    Wacker J, Lucchinetti E, Jamnicki M, Aguirre J, Härter L, Keel M, Zaugg M.
    Anesth Analg; 2008 Jun 15; 106(6):1749-58. PubMed ID: 18499605
    [Abstract] [Full Text] [Related]

  • 32. Adenosine inhibition of adenosine diphosphate and thrombin-induced monocyte-platelet aggregates in cardiac syndrome X.
    Aurigemma C, Scalone G, Fattorossi A, Sestito A, Lanza GA, Crea F.
    Thromb Res; 2009 May 15; 124(1):116-20. PubMed ID: 19185336
    [Abstract] [Full Text] [Related]

  • 33. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ, Holmes CE, Serrano FA, Sobel BE, Schneider DJ.
    Am J Cardiol; 2007 Aug 15; 100(4):722-7. PubMed ID: 17697836
    [Abstract] [Full Text] [Related]

  • 34. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
    Pfeiffer S, Zorn GL, Zhang JP, Giorgio TD, Robson SC, Azimzadeh AM, Pierson RN.
    Transplantation; 2003 Apr 15; 75(7):953-9. PubMed ID: 12698079
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
    Tetik S, Uras F, Ekşioğlu-Demiralp E, Turay Yardimci K.
    Clin Appl Thromb Hemost; 2008 Apr 15; 14(2):210-9. PubMed ID: 18160616
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
    Mirabet M, Barrabés JA, Quiroga A, Garcia-Dorado D.
    Mol Immunol; 2008 Feb 15; 45(4):937-44. PubMed ID: 17959249
    [Abstract] [Full Text] [Related]

  • 40. Involvement of SNARE proteins in thrombin-induced platelet aggregation: evidence for the relevance of Ca2+ entry.
    Jardin I, Ben Amor N, Hernández-Cruz JM, Salido GM, Rosado JA.
    Arch Biochem Biophys; 2007 Sep 01; 465(1):16-25. PubMed ID: 17543880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.